Evidence map›Paper›PMID 36405492›Full record

ReviewNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia2022

[Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients.]

Verónica López, Auxiliadora Mazuecos, Florentino Villanego, María López-Oliva, Angel Alonso, Isabel Beneyto, Marta Crespo, Carmen Díaz-Corte, Antonio Franco, Francisco González-Roncero and 13 more

Open access · diamondAbstract readEnglish AbstractReview
In one paragraph

Review in Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 20 institutions in 1 country.

Verónica LópezUnidad de Gestión Clínica de Nefrología. Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), RICORS2040 (RD21/0005/0012), Málaga, España.
Auxiliadora MazuecosServicio de Nefrología. Hospital Universitario Puerta del Mar, Cádiz, España.
Florentino VillanegoServicio de Nefrología. Hospital Universitario Puerta del Mar, Cádiz, España.
María López-OlivaServicio de Nefrología. Hospital La Paz, Madrid, España.
Angel AlonsoServicio de Nefrología. Complejo Hospitalario A Coruña, España.
Isabel BeneytoServicio de Nefrología. Hospital Universitario Politécnico La Fe, Valencia, España.
Marta CrespoServicio de Nefrología. Hospital del Mar, Hospital del Mar Medical Research Institute (IMIM), Barcelona, España. RD16/0009/0013 (ISCIII FEDER REDinREN), España.
Carmen Díaz-CorteServicio de Nefrología. Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, España.
Antonio FrancoServicio de Nefrología. Hospital de Alicante, Alicante, España.
Francisco González-RonceroServicio de Nefrología. Hospital Virgen del Rocío, Sevilla, España.
Luis GuiradoServicio de Nefrología. Fundación Puigvert, REDinREN RD16/0009/0019, Barcelona, España.
Carlos JiménezServicio de Nefrología. Hospital La Paz, Madrid, España.
Javier JuegaServicio de Nefrología. Hospital Trias i Pujol, REDinREN RD16/0009/0032, Barcelona, España.
Santiago LlorenteServicio de Nefrología. Hospital Virgen de la Arrixaca, Murcia, España.
Javier PaulServicio de Nefrología. Hospital Miguel Servet, Zaragoza, España.
Alberto Rodríguez-BenotServicio de Nefrología. Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, España.
Juan Carlos RuizServicio de Nefrología. Hospital Marqués de Valdecilla, IDIVAL, REDinREN RD16/0009/0027, Santander, España.
Ana Sánchez-FructuosoSerivicio de Nefrología. Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid, España.
Vicente TorregrosaServicio de Nefrología. Hospital Clinic, Barcelona, España.
Sofía ZárragaServicio de Nefrología. Hospital de Cruces, Bilbao, España.
Emilio RodrigoServicio de Nefrología. Hospital Marqués de Valdecilla, IDIVAL, REDinREN RD16/0009/0027, Santander, España.
Domingo HernándezUnidad de Gestión Clínica de Nefrología. Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), RICORS2040 (RD21/0005/0012), Málaga, España.
Grupo de Estudio GREAT y SENTRA
Hospital Universitario La Paz · ESHospital Universitario Puerta del Mar · ESComplexo Hospitalario Universitario A Coruña · ESHospital Clínic de Barcelona · ESHospital de Cruces · ESHospital Del Mar · ESHospital General Universitario de Alicante Doctor Balmis · ESHospital Regional Universitario de Málaga · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario Miguel Servet · ESHospital Universitario Virgen de la Arrixaca · ESHospital Universitario Virgen del Rocío · ESInstituto de Investigación Marqués de Valdecilla · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESMarqués de Valdecilla University Hospital · ESPuigvert Foundation · ESUniversidad Complutense de Madrid · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected to be higher due to their immunosuppressed condition and the frequent associated comorbidities. Since the beginning of the pandemic in March 2020 we have rapidly improved our knowledge about the epidemiology, clinical features and management of COVID-19 post-transplant, resulting in a better prognosis for our patients. KT units have been able to adapt their programs to this new reality, normalizing both donation and transplantation activity in our country.This manuscript presents a proposal to update the general recommendations for the prevention and treatment of infection in this highly vulnerable population such as KT.

Indexed as

Covid-19immunosuppressedkidney transplantationSARS-CoV-2

Identifiers

PMID36405492
PMCPMC9664833
OpenAlexW4309101329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.